Table 5.
Factors associated with implants discontinuation among implants user women in health facilities of Hawassa city, Southern Ethiopia, 2019 (n = 351)
| Variables | LARCs discontinuation Ye s (%) No (%) |
P-value | AOR (95% C.I) |
|
|---|---|---|---|---|
| Occupation of participant | ||||
| House wife | 71 (47.7%) | 78 (52.3%) | 0.110 | 2.622 (0.855–8.041) |
| Merchant | 30 (48.4%) | 32 (51.6%) | 0.164 | 2.613 (0.801–8.529) |
| Private employee | 27 (57.4%) | 20 (42.6%) | 0.559 | 1.531 (0.456–5.141) |
| Government employee | 32 (49.2%) | 33 (50.8%) | 0.184 | 2.337 (0.71–7.694) |
| Student | 18 (64.3%) | 10 (35.7%) | 1 | |
| Maternal Educational status | ||||
| Unable to read and write | 22 (50.0%) | 22 (50.0%) | 0.663 | 1.423 (0.360–5.633) |
| Read and Write | 23 (59.0%) | 16 (41.0%) | 0.605 | 0.798 (0.235–2.712) |
| Primary | 42 (42.4%) | 57 (57.6%) | 0.115 | 2.240 (0.793–6.329) |
| Secondary | 44 (53.7%) | 38 (46.3%) | 0.962 | 1.095 (0.427–2.811) |
| College and above | 47 (54.0%) | 40 (46.0%) | 1 | |
| Husband‘s educational level | ||||
| Unable to read and write | 13 (48.1%) | 14 (51.9%) | 0.708 | 0.581 (0.159–2.1177) |
| Read and Write | 15 (60.0%) | 10 (40.0%) | 0.465 | 0.351 (0.112–1.118) |
| Primary | 31 (56.4%) | 24 (43.6%) | 0.589 | 0.446 (0.189–1.052) |
| Secondary | 44 (44.0%) | 56 (56.0%) | 0.215 | 0.903 (0.444–1.836) |
| College and above | 75 (52.1%) | 69 (47.9%) | 1 | |
| Ever used contraceptives before implants | ||||
| Yes | 106 (46.1%) | 124 (53.9%) | 0.017 | 1.613 (0.940–2.769) |
| No | 72 (59.5%) | 49 (40.5%) | 1 | |
| Counseling about side effects of implants | ||||
| Yes | 108 (65.5%) | 57 (34.5%) | < 0.0001 | 2.394 (1.422–4.03) ** |
| No | 70 (37.6%) | 116 (62.4%) | 1 | |
| Counseling about benefit of implants | ||||
| Yes | 171 (52.3%) | 156 (47.7%) | 1 | |
| No | 7 (29.2%) | 17 (70.8%) | 0.034 | 2.312 (0.825–6.480) |
| Side effects | ||||
| Yes | 34 (25.0%) | 102 (75.0%) | < 0.0001 | 6.33 (3.719–10.76) *** |
| No | 144 (67.0%) | 71 (33.0%) | 1 | |
| Follow-up | ||||
| Yes | 155 (56.4%) | 120 (43.6%) | 1 | |
| No | 23 (30.3%) | 53 (69.7%) | < 0.0001 | 2.241 (1.186–4.234) * |
Significant at ***p < 0.0001, **p = 0.001, *p = 0.013, AOR Adjusted odds ratio